| Composition: |
Dolutegravir / Lamivudine/ Tenofovir Disoproxil Fumarate Film-Coated Tablet (50mg/300mg/300mg) |
| Indication: |
Indicated for use alone as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing 40 kg or greater. |
| Packing: |
30’s, 90’s & 180’s |
| Composition: |
Tenofovir Alafenamide 25mg tablets |
| Indication: |
Chronic hepatitis B in adults and adolescents |
| Packing: | 30’s |
| Composition: |
Tenofovir Disoproxil Fumarate 300mg tablets |
| Indication: |
For HIV-1 Infection, Chronic Hepatitis B |
| Packing: | 30’s |
| Composition: |
Lamivudine Tablets 150mg |
| Indication: |
Used in combination therapy for HIV infections with a protease inhibitor and or nucleoside reverse transcriptase inhibitors (NRTIs). |
| Packing: |
60’s |
| Composition: |
Nevirapine Tablets USP 200 mg |
| Indication: |
Treatment of HIV-1 infection in combination with other antiretroviral agents. |
| Packing: | 60’s |
| Composition: |
Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg Tablets |
| Indication: |
Treatment in combination with other antiretroviral agents (such as non nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults. Pre-exposure prophy–laxis (PrEP) of HIV-1 infection. |
| Packing: | 30’s |
| Composition: | Lamivudine oral solution 10mg/ml |
| Indication: | Treatment of HIV infection in combination with other antiretroviral agents. |
| Packing: | 240 ml |
| Composition: | Nevirapine oral suspension 50mg/5ml |
| Indication: | Treatment of HIV-1 infection in combination with other antiretroviral agents. |
| Packing: | 100 ml |
| Composition: | Nevirapine oral suspension 50mg/5ml |
| Indication: | Treatment of HIV-1 infection in combination with other antiretroviral agents. |
| Packing: | 240 ml |
| Composition: | Efavirenz tablets USP 600mg |
| Indication: | Used in combination therapy for HIV infections with a protease inhibitor and or nucleoside reverse transcriptase inhibitors (NRTIs). |
| Packing: | 30’s |
| Composition: | Efavirenz 600 mg, Lamivudine 300 mg Tenofovir Disoproxil Fumarate 300 mg Film-coated Tablets |
| Indication: | Treatment of human immunodeficiency virus-1 (HIV-1) infection in adults and adolescents (from 12 years of age and weighing ≥ 40 kg) with virologic suppression to HIV-1 RNA levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. |
| Packing: | 30 tabs / bottle |
| Composition: | Sofosbuvir and Velpatasvir (400mg/100mg) |
| Indication: | Pan-genotype treatment of chronic hepatitis C virus (HCV) infection in adults. |
| Packing: | 28’s |
| Composition: | Sofosbuvir Tablets 400 mg |
| Indication: | Combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults |
| Packing: | 28’s |
